Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00930_DB01118 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00930_DB01118 label "DDI between Colesevelam and Amiodarone - Bile Acid Sequestrants may decrease the bioavailability of Amiodarone. Consider alternative antilipemic agent. The risk of subtherapeutic amiodarone serum concentrations when such is being used for the treatment of malignant arrhythmias can be very large. The effect (ie, reduced risk) of separating doses of these agents is unknown. Amiodarone should be administered at least 1 hour before or 4 hours after colesevelam.1 Similar dosing with other agents seems warranted. [drugbank_resource:DB00930_DB01118]" assertion.
- drugbank_resource:DB00930_DB01118 identifier "drugbank_resource:DB00930_DB01118" assertion.
- drugbank_resource:DB00930_DB01118 title "DDI between Colesevelam and Amiodarone - Bile Acid Sequestrants may decrease the bioavailability of Amiodarone. Consider alternative antilipemic agent. The risk of subtherapeutic amiodarone serum concentrations when such is being used for the treatment of malignant arrhythmias can be very large. The effect (ie, reduced risk) of separating doses of these agents is unknown. Amiodarone should be administered at least 1 hour before or 4 hours after colesevelam.1 Similar dosing with other agents seems warranted." assertion.
- drugbank:DB01118 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01118 assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00930_DB01118 assertion.